
AgeX Therapeutics, Inc.
AMEX:AGE
0.4302 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 0.345 | 0.645 | 0.584 | 0.527 | 2.352 | 6.707 | 7.375 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.345 | 0.645 | 0.584 | 0.527 | 2.352 | 6.707 | 7.375 |
Net Receivables
| 0.057 | 0.004 | 0.025 | 0.326 | 0.363 | 0.131 | 0.107 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.352 | 1.804 | 1.625 | 1.43 | 1.339 | 1.015 | 0.111 |
Total Current Assets
| 0.754 | 2.453 | 2.234 | 2.283 | 4.054 | 7.853 | 7.593 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 1.126 | 0.09 | 0.129 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.607 | 0.738 | 0.87 | 1.592 | 2.151 | 2.709 | 1.874 |
Goodwill and Intangible Assets
| 0.607 | 0.738 | 0.87 | 1.592 | 2.151 | 2.709 | 1.874 |
Long Term Investments
| 10.604 | 0.05 | 0.05 | 0.05 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | 0 | 0.111 | 0.019 | 0.035 |
Total Non-Current Assets
| 11.211 | 0.788 | 0.92 | 1.642 | 3.388 | 2.818 | 2.038 |
Total Assets
| 11.965 | 3.241 | 3.154 | 3.925 | 7.442 | 10.671 | 9.631 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 1.413 | 1.034 | 0.771 | 1.428 | 1.319 | 1.416 | 0.511 |
Short Term Debt
| 3.672 | 7.646 | 7.14 | 2.396 | 0.428 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0.07 | 0.275 | 0.283 | 0.317 | 0.18 |
Other Current Liabilities
| 0.829 | 1.398 | 1.056 | 1.258 | 1.267 | 0.707 | 0.621 |
Total Current Liabilities
| 5.914 | 10.078 | 8.967 | 5.357 | 3.297 | 2.44 | 1.312 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0.693 | 10.478 | 6.062 | 3.9 | 1.528 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0.064 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | -3.9 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0.693 | 10.478 | 6.062 | 3.964 | 1.528 | 2.123 | 0 |
Total Liabilities
| 6.607 | 20.556 | 15.029 | 9.321 | 4.825 | 2.44 | 1.312 |
Equity: | |||||||
Preferred Stock
| 11.965 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0 | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 | 0.003 |
Retained Earnings
| -131.013 | -116.21 | -105.748 | -97.073 | -86.208 | -74.054 | -66.552 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0.143 | 0.069 | -0.002 | 0.068 |
Other Total Stockholders Equity
| 136.482 | 98.994 | 93.912 | 91.81 | 88.353 | 81.499 | 73.761 |
Total Shareholders Equity
| 5.469 | -17.212 | -11.832 | -5.116 | 2.218 | 7.447 | 7.28 |
Total Equity
| 5.358 | -17.315 | -11.875 | -5.396 | 2.617 | 8.231 | 0 |
Total Liabilities & Shareholders Equity
| 11.965 | 3.241 | 3.154 | 3.925 | 7.442 | 10.671 | 9.631 |